Inclusion complexation of loratadine with natural and modified cyclodextrins: Phase solubility and thermodynamic studies

Journal of Solution Chemistry

Volumn 36, Issue 5, 2007, Pages 605-616

  Omar, L ^a   El Barghouthi, M I ^a   Masoud, N A ^a   Abdoh, A A ^b   Al Omari, M M ^b   Zughul, M B ^c   Badwan, A A ^b  

^a HASHEMITE UNIVERSITY   (Jordan)

^b JORDANIAN PHARMACEUTICAL MANUFACTURING COMPANY   (Jordan)

^c UNIVERSITY OF JORDAN   (Jordan)

Author keywords

Cyclodextrins; Hydrophobic effect; Inclusion complexes; Loratadine; Molecular mechanical modeling; Phase solubility diagrams; Thermodynamics

Indexed keywords

EID: 34249683676     PISSN: 00959782     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10953-007-9136-3     Document Type: Article

References (22)

1. Duchene, D.: Cyclodextrins and their industrial uses. Editions de Sante', Paris (1987)
2. Szejtli, J.: Introduction and general overview of cyclodextrin chemistry. Chem. Rev. 98, 1743-1754 (1998)
3. Tabushi, I., Kiyosuke, Y., Sugimoto, T., Yamamura, K.: Approach to the aspects of driving force of inclusion by α-cyclodextrin. J. Am. Chem. Soc. 100, 916-919 (1978)
4. Rekharsky, M.V., Inoue, Y.: Complexation thermodynamics of cyclodextrins. Chem. Rev. 98, 1875-1918 (1998)
5. Duchene, D., Wouessidjewe, D.: Pharmaceutical uses of cyclodextrins and derivatives. Drug Dev. Ind. Pharm. 16, 2487-2499 (1990)
6. Loftsson, T., Brewster, M.E.: Pharmaceutical applications of cyclodextrins. 1. Drug solubilization and stabilization. J. Pharm. Sci. 85, 1017-1025 (1996)
7. Hedges, A.R.: Industrial applications of cyclodextrins. Chem. Rev. 98, 2035-2044 (1998)
8. Mura, P., Maestrelli, F., Cirri, M.: Ternary systems of naproxen with hydroxypropyl-β-cyclodextrin and aminoacids. Int. J. Pharm. 260, 293-302 (2003)
9. 1-antihistaminic agents in relation to their central sedative side-effects. Eur. J. Pharm. Sci. 2, 373-384 (1994)
10. 3H]loratadine). Eur. J. Pharm. Sci. 4, 307-319 (1996)
11. Seghal, A., Srivastava, J., Arora, V.K. : Nasal pharmaceutical compositions of loratadine. Patent No. WO 2004082589 A2. Application No. WO 2004-IB839 (2004)
12. Abdel-Rahman, S.I., Ahmad, S.M., Samy, I.M., Badawy, A.M.M.: Interactions of loratadine with cyclodextrins. Ethiop. Pharm. J. 17, 1-19 (1999)
13. 2 type phase solubility diagrams, complex formation and chemical speciation of soluble species. J. Incl. Phenom. Mol. Recognit. Chem. 31, 243-264 (1998)
14. 2L-type complexes. Int. J. Pharm. 151,109-119(1997)
15. Zughul, M.B., Al-Omari, M., Badwan, A.A.: Thermodynamics of propyl paraben/β-cyclodextrin inclusion complexes. Pharm. Dev. Tech. 3, 43-53 (1998)
16. El-Barghouthi, M.I., Masoud, N.A., Al-Kafawein, J.K., Zughul, M.B., Badwan, A.A.: Host-guest interactions of risperidone with natural and modified cyclodextrins: phase solubility, thermodynamics and molecular modeling studies. J. Incl. Phenom. Macrocycl. Chem. 53, 15-22 (2005)
17. Higuchi, T., Connors, K.A.: Phase solubility techniques. In: Reilly, C.N. (ed.) Advances in Analytical Chemistry and Instrumentation, vol. 4, pp. 117-212 (1965)
18. Kopecky, F., Kopecka, B., Kaclik, P.: Solubility study of nimodipine inclusion complexation with α- and β-cyclodextrin and some substituted cyclodextrins. J. Incl. Phenom. Macrocycl. Chem. 39, 215-217 (2001)
19. Puliti, R., Mattia, C.A., Paduano, L.: Crystal structure of a new a-cyclodextrin hydrate form. Molecular geometry and packing features: disordered solvent contribution. Carbohydr. Res. 310, 1-8 (1998)
20. Linder, K., Saenger, W.: Crystal and molecular structure of cyclohepta-amylose dodecahydrate. Carbohydr. Res. 99, 103-115 (1982)
21. Saenger, W, Jacob, J., Gessler, K., Steiner, T., Hoffman, D., Sanbe, H., Koizumi, K., Smith, S.M., Takaha, T.: Structure of the common cyclodextrins and their larger analogues-beyond doughnut. Chem. Rev. 98, 1787-1802 (1998)
22. Harata, K.: The structure of the cyclodextrin complex. 20. Crystal-structure of uncomplexed hydrated gamma-cyclodextrin. Bull. Chem. Soc. Jpn. 60, 2763-2767 (1987)